Regulatory scrutiny will continue to cap the sales by life insurers of short-term low-margin savings-type products at subdued levels, thereby supporting a stabilisation in solvency ratios in the coming quarters, notes S&P.
Please login to read the full news
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »